|
Volumn 38, Issue 5, 2006, Pages 1293-1294
|
Switching From Cyclosporine to Tacrolimus Leads to Improved Disease-Specific Quality of Life in Patients After Kidney Transplantation
a a,b b |
Author keywords
[No Author keywords available]
|
Indexed keywords
CORTICOSTEROID;
CYCLOSPORIN;
IMMUNOSUPPRESSIVE AGENT;
TACROLIMUS;
ADULT;
ARTICLE;
CARDIOTOXICITY;
CARDIOVASCULAR DISEASE;
CONTROLLED STUDY;
DISTRESS SYNDROME;
DRUG EFFECT;
DRUG EFFICACY;
DRUG INDUCED DISEASE;
DRUG SUBSTITUTION;
FEMALE;
GINGIVA DISEASE;
HAIR DISEASE;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
KIDNEY ALLOGRAFT;
KIDNEY DYSFUNCTION;
KIDNEY GRAFT REJECTION;
KIDNEY TRANSPLANTATION;
MAJOR CLINICAL STUDY;
MALE;
METABOLIC DISORDER;
PERIODONTAL DISEASE;
POSTOPERATIVE PERIOD;
PRIORITY JOURNAL;
PROGNOSIS;
QUALITY OF LIFE;
RECIPIENT;
SCORING SYSTEM;
SHORT FORM 36;
SKIN TOXICITY;
ADULT;
AGED;
COGNITION;
CYCLOSPORINE;
FEMALE;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
KIDNEY TRANSPLANTATION;
MALE;
MIDDLE AGED;
MOTOR ACTIVITY;
QUALITY OF LIFE;
STRESS, PSYCHOLOGICAL;
TACROLIMUS;
|
EID: 33745216195
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/j.transproceed.2006.02.081 Document Type: Article |
Times cited : (16)
|
References (4)
|